Where is Albemarle located?

Albemarle is headquartered in South Haven, United States.

Is Albemarle a funded company?

Albemarle is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Albemarle rank among its competitors?

Albemarle ranks 741st amongst 970 active competitors, of which 38 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Enaltec Labs, which secured $1.33M in Jan, 2022.

Who are the top competitors of Albemarle?

Albemarle's top competitors include Symbiotec, Neuland and Hikal. Among them, Enaltec Labs secured the most recent funding round in January, 2022.

Albemarle - 2026 Company Profile & Competitors

Most viewed in 2019

Albemarle is an unfunded company based in South Haven (United States), founded in 2019. It operates as a Manufacturer of intermediates and APIs. Albemarle has not raised any funding yet. The company has 970 active competitors, including 38 funded and 149 that have exited. Its top competitors include companies like Symbiotec, Neuland and Hikal.

Key Metrics

Founded Year

2019

Location

South Haven, United States

Stage

Unfunded

Ranked

741^st among 970 active competitors

Similar Companies

Symbiotec & 1234 more

View Albemarle's full profile

Albemarle has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Albemarle include Symbiotec, Neuland and Hikal. Here is the list of Top 10 competitors of Albemarle, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Symbiotec 2002, Indore (India), Acquired	Manufacturer of non sterile steroid hormone based APIs and intermediates	$61.1M	Franklin Templeton Investments, Actis & 21 others	63/100
2nd	Neuland 1984, Hyderabad (India), Public	Manufacturer of active pharmaceutical ingredients (APIs) and peptides	-	InvAscent, Evolvence & 1 others	58/100
3rd	Hikal 1988, Mumbai (India), Public	Traditional company offering contract research, custom synthesis & custom manufacturing of APIs and intermediates	-	IFC	57/100
4th	Beijing Biostar Technologies 2002, Beijing (China), Public	Developer and manufacturer of APIs, intermediates, & biochemical reagents	$135M	cdkjfw.cn, SDIC Venture Capital Management ... & 9 others	55/100
5th	IDT Australia Limited 1975, Boronia (Australia), Public	Providing cannabis product development and manufacturing services from API	$6M	CVC, I'Rom Group	54/100
6th	Embio 1986, Mumbai (India), Early Stage	Contract research and manufacturing company engaged in APIs and chiral intermediates	$292K	UTI, GURU NARAYAN FINCAP & 25 others	53/100
7th	SMS LifeSciences 2006, Hyderabad (India), Public	Manufacturer of Active Pharmaceutical Ingredients (API) and intermediate	-	-	53/100
8th	ST PHARM 2008, Siheung si (South Korea), Public	CDMO providing oligonucleotide, mRNA, and small molecule services	-	Shinhan Venture Investment, Synergy IB investment ... & 1 others	52/100
9th	Enaltec Labs 2006, Mumbai (India), Acquired	Non-oncology API developer and manufacturer	$8.56M	InvAscent, Medtech Global & 7 others	52/100
10th	Qilu Pharmaceutical Group 1958, Jinan (China), Funding Raised	Developer and manufacturer of APIs and intermediates	-	Yijing Capital	51/100
741st	Albemarle 2019, South Haven (United States), Unfunded	Manufacturer of intermediates and APIs	-	-	18/100